A major biotech firm is axing hundreds of jobs, and Bay Area employees are bearing the brunt of the latest cuts. Genentech, one of the world's largest biotechnology companies and a subsidiary of Swiss ...
DUBLIN and WILSONVILLE, Ore., March 10, 2026 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management ...
Sana's allogeneic HIP technology achieved a first in T1D, showing insulin production and immune evasion without immunosuppression, but scalability remains unproven. Despite promising early data, Sana ...
DENVER, Aug. 11, 2026 (GLOBE NEWSWIRE) -- NeOnc Technologies (NASDAQ:NTHI) is heading into Wednesday with the kind of setup that can put a clinical-stage biotech squarely on the market’s radar: a ...
In the world of biotechnology investing, companies often struggle to bring new drugs to market. Developing treatments for rare diseases can be incredibly expensive, and because these conditions affect ...
Sana Biotechnology has announced a fundamental shift in its corporate direction, choosing to concentrate its efforts exclusively on two primary development programs. This strategic realignment ...
The worldwide need for healthcare and biotech products is experiencing a steady upsurge fueled by various factors, such as a heightened emphasis on personalized medicine. Therefore, it could be wise ...
RIYADH, SAUDI ARABIA, Sept. 17, 2026 (GLOBE NEWSWIRE) -- The Riyadh Global Medical Biotechnology Summit closed today as a major success in its fourth edition and a clear statement of the scale of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results